Janee Kiernan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janee kiernan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janee Kiernan Today - Breaking & Trending Today

Treace Medical Concepts Appoints New Directors

PONTE VEDRA, Fla., Sept. 27, 2022 (GLOBE NEWSWIRE) Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology. ....

United States , Lance Berry , Janee Kiernan , Jane Kiernan , Lancee Berry , Jamest Treace , Priveterra Acquisition Corp , Southern Methodist University , Company Nasdaq , Baxter Healthcare Corporation , Arthur Andersen , Wright Medical Group , University Of Mississippi , Treace Medical Concepts Inc , Surgimatix Inc , Allegiance Healthcare Corporation , Medical Concepts , Corporate Controller , Senior Vice President , Chief Financial Officer , Executive Vice President , Chief Financial , Operations Officer , Wright Medical , Certified Public Accountant , Chief Business Officer ,

Axonics (NASDAQ:AXNX) Given New $77.00 Price Target at Needham & Company LLC

Axonics (NASDAQ:AXNX – Get Rating) had its price objective hoisted by Needham & Company LLC from $60.00 to $77.00 in a research note released on Tuesday morning, The Fly reports. Needham & Company LLC currently has a buy rating on the stock. Several other research analysts have also recently issued reports on AXNX. Truist Financial […] ....

New York , United States , New Jersey , Janee Kiernan , Zurcher Kantonalbank Zurich Cantonalbank , Piper Sandler , Allspring Global Investments Holdings , York State Common Retirement Fund , Axonics Inc , Jersey Common Pension Fund , Needham Company , Wells Fargo Company , Worldwide Group Holding , Wolfe Research , Get Rating , Director Jane , Global Investments Holdings , Kantonalbank Zurich Cantonalbank , New York State Common Retirement Fund , Nasdaq Axnx , Boost Price Target , Needham Company Llc ,

Axonics (NASDAQ:AXNX) Upgraded to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Axonics (NASDAQ:AXNX – Get Rating) from a sell rating to a hold rating in a research note published on Friday morning, Zacks.com reports. According to Zacks, “Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction […] ....

United States , Janee Kiernan , Raymondw Cohen , Piper Sandler , Allspring Global Investments Holdings , Axonics Inc , Securities Exchange Commission , Axonics Modulation Technologies Inc , Goldman Sachs Group Inc , Zacks Investment Research , Norges Bank , Blackrock Inc , Needham Company , Marshall Wace , Wolfe Research , Axonics Company Profile Get Rating , Get Rating , Modulation Technologies , Exchange Commission , Director Jane , Global Investments Holdings , Sachs Group , Company Profile , Nasdaq Axnx ,